Lv3
236 积分 2024-11-29 加入
N6-Methyladenosine Modification in Vascular Smooth Muscle Disease: A Review
3天前
已关闭
Amivantamab Plus Lazertinib in Patients With EGFR-mutant Non-small Cell Lung Cancer (NSCLC) After Progression on Osimertinib and Platinum-based Chemotherapy: Results From CHRYSALIS-2 Cohort A
3个月前
已完结
Non-invasive plasma testing for CD274 UTR structural variations by next-generation sequencing in cancer
3个月前
已完结
Targeting tumor-infiltrating tregs for improved antitumor responses
3个月前
已完结
Phase I trial of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumors
3个月前
已完结
First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study
3个月前
已完结
gC1qR: A New Target for Cancer Immunotherapy
3个月前
已完结
Optimized CAR-T therapy based on spatiotemporal changes and chemotactic mechanisms of MDSCs induced by hypofractionated radiotherapy
3个月前
已完结
Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors
3个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
3个月前
已完结
皖公网安备34019202002308
